Balanced news tone
News Sentiment
MDXG sentiment intelligence
MiMedx Group Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
51
Balanced news tone
64 relevant articles
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
+4.1% over one week, +14.2% over four weeks, trend inactive, and below fair value.
MiMedx Group (MDXG) Cantor Global Healthcare Conference 2025 Summary
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
82/100 classification
One-week reaction
4.1%
Price confirming higher
Trend fit
Trend inactive
14.2% over four weeks
Fair value
-39.6%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
9
Neutral
49
Negative
6
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Quartr
Direct company coverage
MiMedx Group (MDXG) AGM 2026 Summary
This article summarizes MiMedx Group (MDXG)'s 2026 Annual General Meeting (AGM) held virtually on June 10, 2026. Key items included the introduction of director nominees, an advisory vote on executive compensation, and the ratification of Deloitte & Touche LLP as the independent
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 11:41
- Source
- Quartr
Market source
Direct company coverage
How The MiMedx Group (MDXG) Story Is Shifting As Analysts Rework Price Targets
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jun 2026 07:00
- Source
- Market source
GlobeNewswire
Direct company coverage
MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 12:45
- Source
- GlobeNewswire
PR Newswire
Direct company coverage
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- PR Newswire
simplywall.st
Industry context
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Zacks
Direct company coverage
Is the Options Market Predicting a Spike in MiMedx Group Stock?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 May 2026 18:36
- Source
- Zacks
simplywall.st
Industry context
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Seeking Alpha
Direct company coverage
MiMedx: The Hard Math Behind My Downgrade To Hold
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 09 May 2026 07:00
- Source
- Seeking Alpha
MT Newswires
Direct company coverage
MiMedx Launches G4Derm Plus Wound-Care Product Across US
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 May 2026 12:44
- Source
- MT Newswires
GlobeNewswire
Direct company coverage
MIMEDX Announces Launch of G4Derm® Plus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 May 2026 12:00
- Source
- GlobeNewswire
Market source
Direct company coverage
Some May Be Optimistic About MiMedx Group's (NASDAQ:MDXG) Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
How Reimbursement Shifts Are Rewriting The MiMedx Group (MDXG) Investment Narrative
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
MiMedx Group, Inc. (NASDAQ:MDXG) Analysts Are Cutting Their Estimates: Here's What You Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 May 2026 07:00
- Source
- Market source
Insider Monkey
Direct company coverage
MiMedx Group (MDXG) Launches CHORIOFIX Placental Allograft for Complex, Tunneling Wounds
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 09:22
- Source
- Insider Monkey
GlobeNewswire
Direct company coverage
MIMEDX Announces First Quarter 2026 Operating & Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Apr 2026 07:00
- Source
- GlobeNewswire
Market source
Direct company coverage
MiMedx (MDXG) Reports Q1 Loss, Tops Revenue Estimates
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 29 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Northland Reaffirms Outperform Rating for MiMedx Group (MDXG)
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 26 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Earnings Preview: MiMedx (MDXG) Q1 Earnings Expected to Decline
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
MiMedx (NASDAQ: MDXG) launches $40M savings plan amid Wound Care slowdown
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
MIMEDX cuts $40M in annual costs as wound-care recovery lags
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
How The MiMedx Group (MDXG) Story Is Shifting With Medicare And Analyst Revisions
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 05 Apr 2026 07:00
- Source
- Market source
TradingView
Industry context
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
DirectorsTalk Interviews
Direct company coverage
MiMedx Group, Inc (MDXG) Stock Analysis: A Biotech Powerhouse with Nearly 100% Upside Potential
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Mar 2026 08:00
- Source
- DirectorsTalk Interviews
Stocktwits
Direct company coverage
MDXG Stock Rises As MiMedx Enters Into Exclusive Distribution Agreement For Three Products
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- Stocktwits
simplywall.st
Direct company coverage
Investors Interested In MiMedx Group, Inc.'s (NASDAQ:MDXG) Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 Jan 2026 08:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
MiMedx (MDXG): Fresh Clinical Evidence Spurs a Closer Look at the Stock’s Valuation and Long-Term Upside Potential
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 21 Dec 2025 08:00
- Source
- simplywall.st